Evidence map›Paper›PMID 30157832›Full record

ArticleBMC musculoskeletal disorders2018

Phospholipase C signaling activated by parathyroid hormone mediates the rapid osteoclastogenesis in the fracture healing of orchiectomized mice.

Wei Li, Liang Yuan, Guojun Tong, Youhua He, Yue Meng, Song Hao, Jianting Chen, Jun Guo, Richard Bringhurst, Dehong Yang

Open access · goldAbstract read
In one paragraph

Article in BMC musculoskeletal disorders, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Aqueous Extract ofFrontiers in pharmacology · 2020
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Wei LiDepartment of Spinal Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Liang YuanDepartment of Spinal Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Guojun TongDepartment of Spinal Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Youhua HeDepartment of Spinal Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Yue MengDepartment of Spinal Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Song HaoDepartment of Spinal Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Jianting ChenDepartment of Spinal Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Jun GuoEndocrine Unit, Massachusetts General Hospital, Boston, MA, 02114, USA.
Richard BringhurstEndocrine Unit, Massachusetts General Hospital, Boston, MA, 02114, USA.
Dehong YangDepartment of Spinal Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. smu_yangdehong2018@163.com.
Southern Medical University · CNNanfang Hospital · CNMassachusetts General Hospital · US

Funding

National Natural Science Foundation of China 30973061 and 81272043Natural Science Foundation of Guangdong Province 2015A030313256
6 · The paper itself

Abstract

backgroundThe age-related osteoporosis is an increasing risk severely threatening the live quality of aged people. Human parathyroid hormone (hPTH) is applied to the therapy of osteoporosis successfully, however, the mechanism, especially the signaling pathway activated in the healing fracture by PTH is still unknown.

methodsThe once daily injections of hPTH(1-34) and GR (1-34) (the PLC deficient analog) into the orchiectomized male mice with bone fracture, were started at the second day after fracture and lasted for 4 weeks. To explore the role of phospholipase C signaling in the androgen-deficient fracture healing, the fracture healing were evaluated via radiography, micro-CT, biomechanics testing, serum biochemistry, bone marrow cell culture and gene expression quantification.

resultsAfter two weeks of fracture, both peptides significantly increased bone mineral density (BMD), bone mass content (BMC) and bone volume (BV/TV) in the healing area. However, compared to hPTH(1-34), GR(1-34) induced more woven bones, the higher BMC and BMD, as well as the less serum TRAP and osteoclasts. After four weeks of treatment, the effects of hPTH(1-34) on fracture healing showed no difference to those of GR(1-34). Consistently, GR(1-34) induced the similar osteogenesis but less osteoclastogenesis under the ex vivo condition immediately after administration compared to hPTH(1-34), which was verified by the weaker activation of RANKL, NFATC1, TRAP and Cathepsin K in GR(1-34) treatment.

conclusionThese results indicated that the PLC signaling activated by the intermittent injection of hPTH(1-34) leads to the bone resorption by rapidly activating the osteoclastogenesis in the fracture healing zone.

Indexed as

AnimalsEnzyme ActivationFemoral Neck FracturesFracture HealingHumansMaleMiceMice, Inbred C57BLOrchiectomyOsteogenesisParathyroid HormoneSignal TransductionType C PhospholipasesParathyroid HormonePTH protein, humanType C PhospholipasesFracture healingOsteoclastogenesisOsteoporosisParathyroid hormonePhopholipase C

Identifiers

PMID30157832
PMCPMC6116492
OpenAlexW2889198832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.